Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01678703
Other study ID # 2trimabort.CTIL
Secondary ID
Status Completed
Phase N/A
First received August 22, 2012
Last updated August 30, 2012
Start date November 2007
Est. completion date June 2010

Study information

Verified date July 2012
Source Wolfson Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

This study compares the effectiveness of cervical preparation before second trimester abortion using laminaria versus vaginal Misoprostol.

The investigators hypothesize that medical preparation of the cervix with vaginal Misoprostol is superior to mechanical preparation using laminaria.

The investigators believe that medical preparation makes the procedure easier to perform, equally safe, without addition of pain or discomfort.


Description:

This is a prospective randomized study.

The aim of the study is to compare preparation of the cervix before surgical abortion with laminaria and misoprostol.

Primary outcome measures will include:

Initial cervical opening and the need for further dilatation at the procedure Procedure duration

Difficulty score performing the abortion

Complications during and after the procedure

Assessment of pain, using VAS scale, and the need for analgesia before and after the procedure


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Female
Age group 15 Years to 45 Years
Eligibility Inclusion Criteria:

- Pregnant patients with a viable singleton

- Pregnancy 14-20 weeks of gestation

- Admitted for termination of pregnancy

Exclusion Criteria:

- Contraindication for administration of Misoprostol

- Patients with more than one previous cesarean section scar

- Patients with impaired coagulation

- Significant pulmonary or cardiac disease

- Non viable pregnancy

- Placenta accreta or previa by ultrasound

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Laminaria, MedGyn Products, Inc. USA.
Insertion of Hygroscopic laminarias into the cervical canal for preparation prior to late surgical abortion. The number of laminarias is according to the cervical compliance.
Drug:
Misoprostol
Cervical preparation with vaginal Misoprostol 600 mcg overnight the day before the abortion

Locations

Country Name City State
Israel Edith Wolfson Medical Center Holon

Sponsors (1)

Lead Sponsor Collaborator
Wolfson Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Other The degree of difficulty to accomplish the abortion The difficulty score will be recorded by the surgeon at the operating room immediately upon completion of the procedure. at the time of performing the surgical abortion No
Primary Initial cervical opening and the need for further dilatation at the start of the procedure The surgical abortion will be performed 8-12 hours after the insertion of laminaria, or after vaginal application of Misoprostol 8-12 hours after insersion of laminaria or Misoprostol Yes
Secondary pain score during cervical preparation and after the procedure The pain score will be accessed immediately after the insertion of the laminaria or the vaginal Misoprostol.
Pain score will be recorded again right before performing the abortion and will address the 8-12 hours elapsed from the insertion.
Another assessment of pain will be recorded immediately after the abortion following recovery from general anesthesia
at the time of the insertion, immediately before the abortion and immediately upon recovery from anesthesia No